Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action

FGF-21 as a novel metabolic regulator

Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125 · see citing works

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · see citing works

Targeting bile‐acid signalling for metabolic diseases

Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422 · see citing works

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151 · see citing works

Fibroblast Growth Factor 21 Corrects Obesity in Mice

Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031 · see citing works

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908 · see citing works

Bile acid biosynthesis

Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819 · see citing works

Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21

Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748 · see citing works

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21

Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738 · see citing works

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesisPreprint

Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 698 · see citing works

βKlotho is required for metabolic activity of fibroblast growth factor 21

Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., & Kuro-o, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701600104 · Cited by 617 · see citing works

Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R. H., Corpuz, R. T., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 580 · see citing works

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576 · see citing works

Cholesterol 7α-hydroxylase

Myant, N. B., & Mitropoulos, K. A. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41693-1 · Cited by 521 · see citing works

A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects

Talukdar, S., Zhou, Y., Li, D., Rossulek, M., Dong, J., Somayaji, V., Weng, Y., Clark, R., Lanba, A., Owen, B. M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.001 · Cited by 496 · see citing works

Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice

Kong, B., Wang, L., Chiang, J. Y. L., Zhang, Y., Klaassen, C. D., & Guo, G. L. (2012) · Hepatology · doi:10.1002/hep.25740 · Cited by 456 · see citing works

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

Lundåsen, T., Gälman, C., Angelin, B., & Rudling, M. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01731.x · Cited by 406 · see citing works

βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism

Ding, X., Boney-Montoya, J., Owen, B. M., Bookout, A. L., Coate, K. C., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.002 · Cited by 403 · see citing works

Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver

Hotta, Y., Nakamura, H., Konishi, M., Murata, Y., Takagi, H., Matsumura, S., Inoue, K., Fushiki, T., & Itoh, N. (2009) · Endocrinology · doi:10.1210/en.2009-0119 · Cited by 352 · see citing works

Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4

Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M. B., Deng, C., & McKeehan, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15482 · Cited by 348 · see citing works

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects

Xu, J., Stanislaus, S., Chinookoswong, N., Lau, Y. Y., Hager, T., Patel, J., Ge, H., Weiszmann, J., Lu, S.-C., Graham, M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00348.2009 · Cited by 340 · see citing works

Liver-specific Activities of FGF19 Require Klotho beta

Lin, B. C., Wang, M., Blackmore, C. A., & Desnoyers, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 284 · see citing works

Effects of Diabetes Mellitus on Cholesterol Metabolism in Man

Bennion, L. J., & Grundy, S. M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706162962401 · Cited by 253 · see citing works

Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho

Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y., & Nabeshima, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23076 · Cited by 245 · see citing works

Transgenic expression of cholesterol 7α‐hydroxylase in the liver prevents high‐fat diet–induced obesity and insulin resistance in mice†

Li, T., Owsley, E., Matozel, M., Hsu, P., Novak, C. M., & Chiang, J. Y. L. (2010) · Hepatology · doi:10.1002/hep.23721 · Cited by 245 · see citing works

Overexpression of Cholesterol 7α-Hydroxylase Promotes Hepatic Bile Acid Synthesis and Secretion and Maintains Cholesterol Homeostasis Δ

Li, T., Matozel, M., Boehme, S., Kong, B., Nilsson, L.-M., Guo, G. L., Ellis, E. C. S., & Chiang, J. Y. L. (2010) · Hepatology · doi:10.1002/hep.24107 · Cited by 225 · see citing works

Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients

Gallego-Escuredo, J. M., Gómez‐Ambrosi, J., Catalán, V., Domingo, P., Giralt, M., Frühbeck, G., & Villarroya, F. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.76 · Cited by 212 · see citing works

Glucose and Insulin Induction of Bile Acid Synthesis

Li, T., Ferrell, J. M., Boehme, S., Ochoa, A., Zhang, Y., Klaassen, C. D., Erickson, S. K., & Chiang, J. Y. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.305789 · Cited by 211 · see citing works

FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation

Wu, X., Ge, H., Lemon, B., Vonderfecht, S., Weiszmann, J., Hecht, R., Gupte, J., Hager, T., Wang, Z.-L., Lindberg, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068783 · Cited by 186 · see citing works

FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways

Wu, A.-L., Coulter, S., Liddle, C., Wong, A., Eastham‐Anderson, J., French, D. M., Peterson, A. S., & Sonoda, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017868 · Cited by 185 · see citing works

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB

Yang, C., Jin, C., Li, X., Wang, F., McKeehan, W. L., & Luo, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033870 · Cited by 173 · see citing works

Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans

Yu, H., Xia, F., Lam, K. S., Wang, Y., Bao, Y., Zhang, J., Gu, Y., Zhou, P., Lu, J., Jia, W., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155184 · Cited by 170 · see citing works

Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho

Fu, T., Choi, S.-E., Kim, D.-H., Seok, S., Suino-Powell, K., Xu, H., & Kemper, J. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1205951109 · Cited by 143 · see citing works

Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling

Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700130200 · Cited by 140 · see citing works

Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy

Walters, J. R. F. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.32 · Cited by 105 · see citing works

Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice

Wu, X., Ge, H., Lemon, B. D., Weiszmann, J., Gupte, J., Hawkins, N., Li, X., Tang, J., Lindberg, R. A., & Li, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907812106 · Cited by 88 · see citing works

C-terminal Tail of FGF19 Determines Its Specificity toward Klotho Co-receptors

Wu, X., Lemon, B. D., Li, X., Gupte, J., Weiszmann, J., Stevens, J. L., Hawkins, N., Shen, W. D., Lindberg, R. A., Chen, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803319200 · Cited by 86 · see citing works

Klotho Coreceptors Inhibit Signaling by Paracrine Fibroblast Growth Factor 8 Subfamily Ligands

Goetz, R., Ohnishi, M., Ding, X., Kurosu, H., Wang, L., Akiyoshi, J., Ma, J.-H., Gai, W.-M., Sidis, Y., Pitteloud, N., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06603-11 · Cited by 76 · see citing works

Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome

Zhang, J., & Li, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.021 · Cited by 73 · see citing works

Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently

Li, X., Fan, X., Ren, F., Zhang, Y., Shen, C., Ren, G., Sun, J., Zhang, N., Wang, W., Ning, G., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.034 · Cited by 60 · see citing works

Fibroblast Growth Factor Receptor 4 (FGFR4) Deficiency Improves Insulin Resistance and Glucose Metabolism under Diet-induced Obesity Conditions

Ge, H., Zhang, J., Gong, Y., Gupte, J., Ye, J., Weiszmann, J., Samayoa, K., Coberly, S. K., Gardner, J., Wang, H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592022 · Cited by 56 · see citing works

Detection of FGF15 in Plasma by Stable Isotope Standards and Capture by Anti-peptide Antibodies and Targeted Mass Spectrometry

Katafuchi, T., Esterházy, D., Lemoff, A. S., Ding, X., Sondhi, V., Kliewer, S. A., Mirzaei, H., & Mangelsdorf, D. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.004 · Cited by 53 · see citing works

Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals

Hao, Y., Zhou, J., Zhou, M., Ma, X., Lu, Z., Gao, M., Pan, X., Tang, J., Bao, Y., & Jia, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072345 · Cited by 49 · see citing works

Characterization of a FGF19 Variant with Altered Receptor Specificity Revealed a Central Role for FGFR1c in the Regulation of Glucose Metabolism

Ge, H., Baribault, H., Vonderfecht, S. L., Lemon, B. D., Weiszmann, J., Gardner, J., Lee, K. J., Gupte, J., Mookherjee, P., Wang, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033603 · Cited by 43 · see citing works

Therapeutic utilities of fibroblast growth factor 19

Wu, X., & Li, Y. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.624514 · Cited by 23 · see citing works

Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism

Pathak, P., Xie, C., Nichols, R. G., Ferrell, J. M., Boehme, S., Krausz, K. W., Patterson, A. D., Gonzalez, F. J., & Chiang, J. Y. L. (2018) · Hepatology · doi:10.1002/hep.29857 · Cited by 567 · see citing works

Metabolic messengers: FGF21

Flippo, K. H., & Potthoff, M. J. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00354-2 · Cited by 311 · see citing works

Fibroblast Growth Factor 21—Metabolic Role in Mice and Men

Staiger, H., Keuper, M., Berti, L., Hrabě de Angelis, M., & Häring, H.-U. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00016 · Cited by 270 · see citing works

FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia

Lan, T., Morgan, D. A., Rahmouni, K., Sonoda, J., Fu, X., Burgess, S. C., Holland, W. L., Kliewer, S. A., & Mangelsdorf, D. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.005 · Cited by 261 · see citing works

Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys

Xiong, Y., Walker, K., Min, X., Hale, C., Tran, T., Komorowski, R., Yang, J., Davda, J., Nuanmanee, N., Kemp, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8732 · Cited by 236 · see citing works

Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis

BonDurant, L. D., & Potthoff, M. J. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064800 · Cited by 222 · see citing works

New developments in the biology of fibroblast growth factors

Ornitz, D. M., & Itoh, N. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1549 · Cited by 143 · see citing works

Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives

Somm, E., & Jornayvaz, F. R. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00134 · Cited by 118 · see citing works

FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases

Sonoda, J., Chen, M. Z., & Baruch, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0002 · Cited by 106 · see citing works

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation

Keinicke, H., Sun, G., Mentzel, C. M. J., Fredholm, M., John, L. M., Andersen, B., Raun, K., & Gerstenberg, M. K. (2020) · Endocrine Connections · doi:10.1530/ec-20-0152 · Cited by 101 · see citing works

Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis

Zhou, J., Huang, N., Guo, Y., Cui, S., Ge, C., He, Q., Pan, X., Wang, G., Wang, H., & Hao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.004 · Cited by 99 · see citing works

FGF21 reverses MASH through coordinated actions on the CNS and liver

Rose, J. P., Morgan, D. A., Sullivan, A. I., Fu, X., Inigo-Vollmer, M., Burgess, S. C., Meyerholz, D. K., Rahmouni, K., & Potthoff, M. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.014 · Cited by 75 · see citing works

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis

Liu, C., Schönke, M., Spoorenberg, B., Lambooij, J. M., van der Zande, H. J. P., Zhou, E., Tushuizen, M. E., Andréasson, A., Park, A., Oldham, S. N., et al. (2023) · eLife · doi:10.7554/elife.83075 · Cited by 72 · see citing works

Fibroblast growth factor-based pharmacotherapies for the treatment of obesity-related metabolic complications

Jin, L., Yang, R., Geng, L., & Xu, A. (2023) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032322-093904 · Cited by 71 · see citing works

An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity

Babaknejad, N., Nayeri, H., Hemmati, R., Bahrami, S., & Esmaillzadeh, A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0623-2909 · Cited by 70 · see citing works

Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling

Ciaula, A. D., Bonfrate, L., Baj, J., Khalil, M., Garruti, G., Stellaard, F., Wang, H. H., Wang, D. Q. ‐., & Portincasa, P. (2022) · Nutrients · doi:10.3390/nu14234950 · Cited by 73 · see citing works

Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway

Kouno, T., Liu, X., Zhao, H., Kisseleva, T., Cable, E. E., & Schnabl, B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102056 · Cited by 67 · see citing works

Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice

Yano, K., Yamaguchi, K., Seko, Y., Okishio, S., Ishiba, H., Tochiki, N., Takahashi, A., Kataoka, S., Okuda, K., Liu, Y. X., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00680-9 · Cited by 63 · see citing works

Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: roles of FGF21 and bile acids

Zhang, H., Zhang, W., Yun, D., Li, L., Zhao, W., Li, Y., Liu, X., & Liu, Z. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108403 · Cited by 59 · see citing works

Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding

Zhou, H. J., Zhou, S.-Y., Gillilland, M. G., Li, J., Lee, A. A., Gao, J. L., Zhang, G., Xu, X., & Owyang, C. (2020) · JCI Insight · doi:10.1172/jci.insight.138881 · Cited by 59 · see citing works

FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression

Gliniak, C. M., Gordillo, R., Youm, Y., Lin, Q., Crewe, C., Zhang, Z., Field, B. C., Fujikawa, T., Virostek, M., Zhao, S., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.011 · Cited by 53 · see citing works

FGF21 acts as a negative regulator of bile acid synthesis

Chen, M. M., Hale, C., Stanislaus, S., Xu, J., & Véniant, M. M. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0727 · Cited by 51 · see citing works

Diabetes and dyslipidemia: characterizing lipoprotein metabolism

TOMKIN, G. H., & Owens, D. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s115855 · Cited by 52 · see citing works

Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk

Alaqil, F. A., Monte, M. J., Peleteiro‐Vigil, A., Briz, Ó., Rosales, R., González, R., Aranda, C. J., Ocón, B., Uriarte, I., de Medina, F. S., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.003 · Cited by 46 · see citing works

Liver-derived FGF21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis

Watanabe, M., Singhal, G., Fisher, F. M., Beck, T. C., Morgan, D. A., Socciarelli, F., Mather, M. L., Risi, R., Bourke, J., Rahmouni, K., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02124-3 · Cited by 44 · see citing works

Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor

Wang, J., Fu, T., Dong, R., Wang, C., Liu, K., Sun, H., Huo, X., Ma, X., Yang, X., & Meng, Q. (2019) · Food & Function · doi:10.1039/c9fo00318e · Cited by 36 · see citing works

Klotho Protein and Cardio-Vascular System

Tyurenkov, I. N., Perfilova, V. N., Нестерова, А. А., & Glinka, Y. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921020024 · Cited by 34 · see citing works

Low-density lipoprotein receptor–related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression

Hamlin, A. N., Chinnarasu, S., Ding, Y., Xian, X., Herz, J., Jaeschke, A., & Hui, D. Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001952 · Cited by 32 · see citing works

Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK–FXR–TGR5 cross‐talk

Zhai, Z., Niu, K., Liu, H., Lin, C., Tu, Y., Liu, Y., Cai, L., Kexian, O., & Liu, J. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15951 · Cited by 30 · see citing works

Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis

Carbonetti, M. P., Almeida‐Oliveira, F., & Majerowicz, D. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2022-0493 · Cited by 24 · see citing works

Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis

Luo, Y., Decato, B. E., Charles, E. D., Shevell, D. E., McNaney, C. A., Shipkova, P. A., Apfel, A., Tirucherai, G., & Sanyal, A. J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100392 · Cited by 23 · see citing works

Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids

Tagawa, R., Kobayashi, M., Sakurai, M., Yoshida, M., Kaneko, H., Mizunoe, Y., Nozaki, Y., Okita, N., Sudo, Y., & Higami, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031793 · Cited by 22 · see citing works

Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass

Guo, J., Chen, H.-H., Lee, W., Chen, S., Lee, S., & Chen, C. (2022) · Nutrients · doi:10.3390/nu14030645 · Cited by 20 · see citing works

Branched-chain amino acids promote hepatic Cyp7a1 expression and bile acid synthesis via suppressing FGF21-ERK pathway

Wang, J., Zhong, M.-Y., Liu, Y., Yu, J.-Y., Wang, Y., Zhang, X., & Sun, H. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01417-2 · Cited by 19 · see citing works

Overexpression of fibroblast growth factor‐21 (FGF‐21) protects mesenchymal stem cells against caspase‐dependent apoptosis induced by oxidative stress and inflammation

Linares, G. R., Leng, Y., Maric, D., & Chuang, D. (2020) · Cell Biology International · doi:10.1002/cbin.11409 · Cited by 19 · see citing works

Effects and possible mechanisms of intermittent fasting on health and disease: a narrative review

Li, Z., Huang, L., Luo, Y., Yu, B., & Tian, G. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad026 · Cited by 20 · see citing works

Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase

Sachdev, V., Duta-Mare, M., Korbelius, M., Vujić, N., Leopold, C., de Boer, J. F., Rainer, S., Fickert, P., Kolb, D., Kuipers, F., et al. (2021) · Cells · doi:10.3390/cells10102619 · Cited by 16 · see citing works

Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach

Suárez, M., Martínez, R., Torres, A., Ramón, A., Blasco, P., & Mateo, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206489 · Cited by 15 · see citing works

Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury

Christidis, G., Karataylı, E., Hall, R. A., Weber, S. N., Reichert, M., Hohl, M., Qiao, S., Boehm, U., Lütjohann, D., Lammert, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157898 · Cited by 15 · see citing works

CD36 Modulates Fasting and Preabsorptive Hormone and Bile Acid Levels

Shibao, C. A., Celedonio, J. E., Tamboli, R. A., Sidani, R. M., Love-Gregory, L. D., Pietka, T., Xiong, Y., Yan, W., Abumrad, N. N., Abumrad, N. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01982 · Cited by 14 · see citing works

Paracrine Fibroblast Growth Factor 1 Functions as Potent Therapeutic Agent for Intrahepatic Cholestasis by Downregulating Synthesis of Bile Acid

Lin, H., Zhou, C., Hou, Y., Li, Q., Qiao, G., Wang, Y., Huang, Z., & Niu, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01515 · Cited by 11 · see citing works

ABL1‒YAP1 axis in intestinal stem cell activated by deoxycholic acid contributes to hepatic steatosis

Mao, T., Xu, X., Liu, L., Wu, Y., Wu, X., Niu, W., You, D., Cai, X., Lu, L., & Zhou, H. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05865-6 · Cited by 10 · see citing works

LKB1 in Intestinal Epithelial Cells Regulates Bile Acid Metabolism by Modulating FGF15/19 Production

Kim, Y., Lee, S., Kim, S., Kim, T., Lee, S.-H., Chang, J., & Kweon, M. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.017 · Cited by 8 · see citing works

Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway

Zhou, C., Pan, X., Huang, L., Wu, T., Zhao, T., Qi, J., Wu, J., Mukondiwa, A. V., Tang, Y., Luo, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166870 · Cited by 7 · see citing works

Insights into the role of FGF21 in coronary heart disease

Zhang, Q.-Y., & Liu, H. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136911 · Cited by 4 · see citing works

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy

Kukla, M., Kierach, R., Skonieczna, M., Hudy, D., Dąbrowski, K., Menżyk, T., Derra, A., Boroń, D., & Grabarek, B. O. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.104419 · Cited by 4 · see citing works

Sodium sulphate ameliorates hypercholesterolemia via the upregulation of Cyp7a1 in hepatocytes and alleviates hepatic insulin resistance via the downregulation of Trib3 in mice with high cholesterol diets

Yang, Y., Yu, S., Rong, H., Lei, Z., Yang, C., Wu, H., Zhang, T., Yang, F., Nie, Y., Chen, L., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12650 · Cited by 4 · see citing works

The value of promoter methylation of fibroblast factor 21 (FGF21) in predicting the course of chronic hepatitis B and the occurrence of oxidative stress

Li, X., Liu, P., Wang, Z., Wei, X.-F., Gao, S., Fan, Y., Liu, H., & Wang, K. (2024) · Virology Journal · doi:10.1186/s12985-024-02605-6 · Cited by 4 · see citing works

Белок клото и сердечно-сосудистая система

Тюренков, И. Н., Perfilova, V. N., Нестерова, А. А., & Глинка, Е. Ю. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521020020 · Cited by 3 · see citing works

Recent advances and future trends in regulating transintestinal cholesterol excretion: Potential for nano-based therapeutic strategies

Wu, X., Zhou, S., & Li, Y. (2026) · Nano Biomedicine and Engineering · doi:10.1016/j.nbe.2025.100035 · Cited by 1 · see citing works

Author response: FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis

Liu, C., Schönke, M., Spoorenberg, B., Lambooij, J. M., van der Zande, H. J. P., Zhou, E., Tushuizen, M. E., Andréasson, A., Park, A., Oldham, S. N., et al. (2023) · eLife · doi:10.7554/elife.83075.sa2 · Cited by 1 · see citing works

Bile acid metabolism in humans : regulation of synthesis and circadian rhythms

Al-Khaifi, A. (2018) · Figshare

Toxicokinetics of recombinant human fibroblast growth factor 21 for injection in cynomolgus monkey for 3 months

Lü, C., Jin, L., Bi, J., Jin, H., You, X., Peng, L., Fan, H., Wang, H., Wang, L., Fan, Z., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1176136

Anti-Hepatic Steatosis Effects of Echinocystic Acid Through Regulation of the Fgfr4/Cyp7a1 Signaling Pathway and Modulating the Gut MicrobiotaPreprint

Xiao, L., Qin, L., Deng, S., Ahmed, J. Z., & Huang, B. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5062517

FGF21 acts as a negative regulator of bile acid synthesis

Chen, M. M., Hale, C., Stanislaus, S., Xu, J., & Véniant, M. M. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0727 · Cited by 51 · see citing works

The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism

Cariello, M., Piglionica, M., Gadaleta, R. M., & Moschetta, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_235 · Cited by 22 · see citing works

THU-008-Circulating fibroblast growth factor 21 regulates bile acids homeostasis in cholestatic patients

Gabbi, C., Anzivino, C., Baldelli, E., Carulli, L., & Bertolotti, M. (2019) · Journal of Hepatology · doi:10.1016/s0618-8278(19)30292-0

MON-163 Lowering of Circulating FGF21 by Modulation of Bile Acid Metabolism in Healthy Males

Al-Khaifi, A., Straniero, S., Rudling, M. J., & Angelin, B. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-mon-163

Expression of fibroblast growth factor 21 in patients with biliary atresia

Li, D., Lu, T., Shen, C., Liu, Y., Zhang, J., Shan, Y., Luo, Y., Xi, Z., Qiu, B., Chen, Q., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.03.003 · Cited by 11 · see citing works